vs

Side-by-side financial comparison of B&G Foods, Inc. (BGS) and CABOT CORP (CBT). Click either name above to swap in a different company.

CABOT CORP is the larger business by last-quarter revenue ($849.0M vs $439.3M, roughly 1.9× B&G Foods, Inc.). CABOT CORP runs the higher net margin — 8.6% vs -4.4%, a 13.0% gap on every dollar of revenue. On growth, B&G Foods, Inc. posted the faster year-over-year revenue change (-4.7% vs -11.1%). CABOT CORP produced more free cash flow last quarter ($57.0M vs $-70.7M). Over the past eight quarters, CABOT CORP's revenue compounded faster (-8.7% CAGR vs -12.8%).

B&G Foods, Inc. is an American branded foods holding company based in Parsippany, New Jersey. The company was formed in 1996 to acquire Bloch & Guggenheimer, a Manhattan-based producer of pickles, relish and condiments which had been founded in 1889.

Cabot Corporation is an American specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company operates in over 20 countries with 36 manufacturing plants, eight research and development facilities, and 28 sales offices.

BGS vs CBT — Head-to-Head

Bigger by revenue
CBT
CBT
1.9× larger
CBT
$849.0M
$439.3M
BGS
Growing faster (revenue YoY)
BGS
BGS
+6.4% gap
BGS
-4.7%
-11.1%
CBT
Higher net margin
CBT
CBT
13.0% more per $
CBT
8.6%
-4.4%
BGS
More free cash flow
CBT
CBT
$127.7M more FCF
CBT
$57.0M
$-70.7M
BGS
Faster 2-yr revenue CAGR
CBT
CBT
Annualised
CBT
-8.7%
-12.8%
BGS

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BGS
BGS
CBT
CBT
Revenue
$439.3M
$849.0M
Net Profit
$-19.1M
$73.0M
Gross Margin
22.5%
24.9%
Operating Margin
2.5%
15.2%
Net Margin
-4.4%
8.6%
Revenue YoY
-4.7%
-11.1%
Net Profit YoY
-356.5%
-21.5%
EPS (diluted)
$-0.24
$1.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BGS
BGS
CBT
CBT
Q4 25
$849.0M
Q3 25
$439.3M
$899.0M
Q2 25
$424.4M
$923.0M
Q1 25
$425.4M
$936.0M
Q4 24
$551.6M
$955.0M
Q3 24
$461.1M
$1.0B
Q2 24
$444.6M
$1.0B
Q1 24
$475.2M
$1.0B
Net Profit
BGS
BGS
CBT
CBT
Q4 25
$73.0M
Q3 25
$-19.1M
$43.0M
Q2 25
$-9.8M
$101.0M
Q1 25
$835.0K
$94.0M
Q4 24
$-222.4M
$93.0M
Q3 24
$7.5M
$137.0M
Q2 24
$3.9M
$109.0M
Q1 24
$-40.2M
$84.0M
Gross Margin
BGS
BGS
CBT
CBT
Q4 25
24.9%
Q3 25
22.5%
24.5%
Q2 25
20.5%
26.4%
Q1 25
21.2%
25.7%
Q4 24
21.5%
24.6%
Q3 24
22.2%
24.0%
Q2 24
20.7%
25.2%
Q1 24
22.9%
24.1%
Operating Margin
BGS
BGS
CBT
CBT
Q4 25
15.2%
Q3 25
2.5%
15.2%
Q2 25
5.2%
18.1%
Q1 25
8.4%
17.3%
Q4 24
-46.6%
16.2%
Q3 24
11.1%
15.0%
Q2 24
9.9%
16.9%
Q1 24
-3.3%
15.3%
Net Margin
BGS
BGS
CBT
CBT
Q4 25
8.6%
Q3 25
-4.4%
4.8%
Q2 25
-2.3%
10.9%
Q1 25
0.2%
10.0%
Q4 24
-40.3%
9.7%
Q3 24
1.6%
13.7%
Q2 24
0.9%
10.7%
Q1 24
-8.5%
8.2%
EPS (diluted)
BGS
BGS
CBT
CBT
Q4 25
$1.37
Q3 25
$-0.24
$0.80
Q2 25
$-0.12
$1.86
Q1 25
$0.01
$1.69
Q4 24
$-2.81
$1.67
Q3 24
$0.09
$2.41
Q2 24
$0.05
$1.94
Q1 24
$-0.51
$1.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BGS
BGS
CBT
CBT
Cash + ST InvestmentsLiquidity on hand
$60.9M
$230.0M
Total DebtLower is stronger
$2.0B
Stockholders' EquityBook value
$470.7M
$1.6B
Total Assets
$2.9B
$3.8B
Debt / EquityLower = less leverage
4.30×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BGS
BGS
CBT
CBT
Q4 25
$230.0M
Q3 25
$60.9M
$258.0M
Q2 25
$54.1M
$239.0M
Q1 25
$61.2M
$213.0M
Q4 24
$50.6M
$183.0M
Q3 24
$54.7M
$223.0M
Q2 24
$40.3M
$197.0M
Q1 24
$42.5M
$206.0M
Total Debt
BGS
BGS
CBT
CBT
Q4 25
Q3 25
$2.0B
$1.1B
Q2 25
$2.0B
Q1 25
$2.0B
Q4 24
$2.0B
Q3 24
$2.1B
$1.1B
Q2 24
$2.0B
Q1 24
$2.0B
Stockholders' Equity
BGS
BGS
CBT
CBT
Q4 25
$1.6B
Q3 25
$470.7M
$1.6B
Q2 25
$501.4M
$1.5B
Q1 25
$513.1M
$1.4B
Q4 24
$524.8M
$1.4B
Q3 24
$755.3M
$1.4B
Q2 24
$765.0M
$1.3B
Q1 24
$781.2M
$1.4B
Total Assets
BGS
BGS
CBT
CBT
Q4 25
$3.8B
Q3 25
$2.9B
$3.8B
Q2 25
$2.9B
$3.8B
Q1 25
$3.0B
$3.8B
Q4 24
$3.0B
$3.6B
Q3 24
$3.4B
$3.7B
Q2 24
$3.4B
$3.6B
Q1 24
$3.4B
$3.6B
Debt / Equity
BGS
BGS
CBT
CBT
Q4 25
Q3 25
4.30×
0.70×
Q2 25
3.97×
Q1 25
3.91×
Q4 24
3.85×
Q3 24
2.75×
0.75×
Q2 24
2.67×
Q1 24
2.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BGS
BGS
CBT
CBT
Operating Cash FlowLast quarter
$-64.6M
$126.0M
Free Cash FlowOCF − Capex
$-70.7M
$57.0M
FCF MarginFCF / Revenue
-16.1%
6.7%
Capex IntensityCapex / Revenue
1.4%
8.1%
Cash ConversionOCF / Net Profit
1.73×
TTM Free Cash FlowTrailing 4 quarters
$54.8M
$401.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BGS
BGS
CBT
CBT
Q4 25
$126.0M
Q3 25
$-64.6M
$219.0M
Q2 25
$17.8M
$249.0M
Q1 25
$52.7M
$73.0M
Q4 24
$80.3M
$124.0M
Q3 24
$4.2M
$204.0M
Q2 24
$11.3M
$207.0M
Q1 24
$35.1M
$176.0M
Free Cash Flow
BGS
BGS
CBT
CBT
Q4 25
$57.0M
Q3 25
$-70.7M
$155.0M
Q2 25
$11.5M
$188.0M
Q1 25
$42.4M
$1.0M
Q4 24
$71.7M
$47.0M
Q3 24
$-679.0K
$112.0M
Q2 24
$5.2M
$155.0M
Q1 24
$27.5M
$133.0M
FCF Margin
BGS
BGS
CBT
CBT
Q4 25
6.7%
Q3 25
-16.1%
17.2%
Q2 25
2.7%
20.4%
Q1 25
10.0%
0.1%
Q4 24
13.0%
4.9%
Q3 24
-0.1%
11.2%
Q2 24
1.2%
15.3%
Q1 24
5.8%
13.1%
Capex Intensity
BGS
BGS
CBT
CBT
Q4 25
8.1%
Q3 25
1.4%
7.1%
Q2 25
1.5%
6.6%
Q1 25
2.4%
7.7%
Q4 24
1.6%
8.1%
Q3 24
1.0%
9.2%
Q2 24
1.4%
5.1%
Q1 24
1.6%
4.2%
Cash Conversion
BGS
BGS
CBT
CBT
Q4 25
1.73×
Q3 25
5.09×
Q2 25
2.47×
Q1 25
63.17×
0.78×
Q4 24
1.33×
Q3 24
0.56×
1.49×
Q2 24
2.87×
1.90×
Q1 24
2.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BGS
BGS

Specialty Segment$150.5M34%
Meals Segment$110.0M25%
Spices And Flavor Solutions Segment$101.4M23%
Frozen And Vegetables Segment$77.4M18%

CBT
CBT

Reinforcement Materials$520.0M61%
Performance Chemicals$300.0M35%
Shipping And Handling$25.0M3%
Other Products And Services$4.0M0%

Related Comparisons